The glutaraldehyde test as a rapid screening method for pulmonary tuberculosis: a preliminary report

Area of Science:

• Medical Diagnostics
• Infectious Disease Research
• Clinical Chemistry

Background:

• Pulmonary tuberculosis (TB) diagnosis relies on clinical and radiological assessments, which can be limited in resource-poor settings.
• There is a need for accessible and cost-effective diagnostic tools for TB screening.
• Glutaraldehyde's reaction with blood components has been explored for diagnostic purposes.

Purpose of the Study:

• To evaluate the utility of a glutaraldehyde blood test for diagnosing pulmonary tuberculosis.
• To compare the gelification time of blood samples from TB patients with control groups.

Main Methods:

• A glutaraldehyde test was performed on 539 individuals, including patients with pulmonary TB, other respiratory diseases, non-respiratory diseases, and healthy volunteers.
• Blood samples were mixed with 2.5% glutaraldehyde solution, and gelification time was recorded.
• Diagnosis of pulmonary TB was based on clinical and X-ray examination.

Main Results:

• Blood from pulmonary TB patients exhibited significantly shorter gelification times compared to controls.
• The glutaraldehyde test demonstrated a sensitivity of 89% and a specificity of 95% when compared to clinical and X-ray diagnoses.
• 238 out of 267 confirmed pulmonary TB cases showed a positive reaction (gelification time < 10 minutes).

Conclusions:

• The glutaraldehyde blood test is a potentially valuable, simple, and inexpensive screening tool for pulmonary tuberculosis.
• This method, combined with clinical examination, could be effective in peripheral health posts in developing countries lacking advanced diagnostic facilities.
• Further validation in diverse settings is recommended to confirm its role in TB case finding.